Supplements for type 2 diabetes mellitus

News

Supplements for Type 2 Diabetes Mellitus: An Overview of Benefits and Recommendations Type 2 diabetes mellitus (T2DM) and related/predisposing conditions (insulin resistance, prediabetes, visceral obesity) have reached epidemic levels. In these metabolic conditions, various dietary supplements, lifestyle improvements, and pharmacological therapy where appropriate, can be beneficial. Among these are fibers, polyphenols, berberine, probiotics, phytosterols, chromium,…

Astaxanthin Regulation: Changes and Adjustments

News

Amendments to the Terms of Use for Astaxanthin-Rich Oleoresin: Analysis of European Commission Regulation (EU) 2023/2852 On December 21, 2023, the Official Journal of the European Union published Commission Implementing Regulation (EU) 2023/2852, dated December 20, 2023, which corrects Commission Implementing Regulation (EU) 2023/1581. The latter regulation amends Implementing Regulation (EU) 2017/2470 regarding the conditions…

Astaxanthin: New Limits and Rules (EU)

News

New Rules on the Use of Astaxanthin: What Changes with Regulation (EU) 2023/1581   The Commission’s Implementing Regulation (EU) 2023/1581, dated August 1, 2023, was published in the Official Journal of the European Union, Series L 194/4 on August 2, 2023. This regulation amends the previous Implementing Regulation (EU) 2017/2470 regarding the conditions of use…

IQVIA Report: Slowed Growth with Sunscreens Rebounding

News

Mercato farmaceutico italiano: Crescita tendenziale in calo a 25 settimane dall’inizio dell’anno The pharmacy market once again shows a declining curve, with a year-to-date growth rate below 1%, a situation not seen since February. Additionally, there has been a contraction of over four points in the number of units sold. This snapshot is captured by…

Efficacy of dietary supplements for insomnia

News

Dietary supplements for insomnia: relationships between individual preconditions, sleep problems, and customization of supplementation Insomnia is one of the most widespread problems of concern in modern society, with a worldwide prevalence of 20%, and is known to cause lifestyle-related diseases such as hypertension, type 2 diabetes mellitus, and depression. Insomnia is classified according to the…

Week 22: pharmacy market slowing down

News

Pharmacy market: Sales data analysis and trends 2023, gradual slowdown and significant decline in several sectors It went from flat to slightly declining the pharmacy market trend curve, which in week 22 falls below 1 percent in values for the first time since February. That’s the snapshot that comes from Iqvia’s report with which it…

Report 2023: pharmaceutical market trends

News

Pharmacy market trend in the 20th week of 2023: Contraction and surprising growth – Iqvia Report It remains flat even in the 20th week of 2023, the week from May 15 to May 21, the trend curve of the pharmacy market, which on a yearly basis remains stationary since the beginning of May around a…

Pharmacy market loses 1.5% year-on-year

News

IQVIA report updates pharmacy market data to the 17th week of 2023 The pharmacy market is also holding the handbrake in the 17th week of 2023, the week from April 24 to 30, losing 1.5 percent in value sales and 6.4 percent in packs on a year-on-year basis compared to the same seven days in…